Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Development of a safer laboratory vervet monkey model for the study of human African trypanosomiasis

View through CrossRef
Background: There are three subspecies of Trypanosoma brucei: T. b. gambiense, T. b. rhodesiense and T. b. brucei. The first two are infectious to humans, whilst T. b. brucei is not. Identifying an animal model of T. b. brucei that mimics human African trypanosomiasis (HAT) would enable researchers to study HAT without subjecting themselves to undue risks such as accidental infection. Objectives: This study assessed the sequential clinical, parasitological and haematological changes in vervet monkeys infected with T. b. brucei.Methods: Three vervet monkeys were infected with a 104 inoculum of T. b. brucei (isolate GUTat 1). Late-stage disease was induced by subcurative treatment with diminazene aceturate 28 days post-infection. The animals were treated curatively with melarsoprol upon relapse. Parasitaemia and clinical signs were monitored daily and, at weekly intervals, the monkeys’ blood and cerebrospinal fluid (CSF) were sampled for haematology and parasitosis assessments, respectively.Results: The first-peak parasitaemia was observed between seven and nine days post-infection. Clinical signs associated with the disease included fever, dullness, pallor of mucous membranes, lymphadenopathy, splenomegaly and oedema. Late-stage signs included stiffness of joints and lethargy. The monkeys developed a disease associated with microcytic hypochromic anaemia. There was an initial decline, followed by an increase, in total white blood cell counts from early- to late-stage disease. Trypanosomes were detected in the CSF and there was a significant increase in white cell counts in the CSF during late-stage disease. Infected vervet monkeys displayed classical clinical symptoms, parasitological and haematological trends that were similar to monkeys infected withT.b. rhodesiense.Conclusion: The T. b. brucei vervet monkey model can be used for studying HAT without putting laboratory technicians and researchers at high risk of accidental infection.
Title: Development of a safer laboratory vervet monkey model for the study of human African trypanosomiasis
Description:
Background: There are three subspecies of Trypanosoma brucei: T.
b.
gambiense, T.
b.
rhodesiense and T.
b.
brucei.
The first two are infectious to humans, whilst T.
b.
brucei is not.
Identifying an animal model of T.
b.
brucei that mimics human African trypanosomiasis (HAT) would enable researchers to study HAT without subjecting themselves to undue risks such as accidental infection.
Objectives: This study assessed the sequential clinical, parasitological and haematological changes in vervet monkeys infected with T.
b.
brucei.
Methods: Three vervet monkeys were infected with a 104 inoculum of T.
b.
brucei (isolate GUTat 1).
Late-stage disease was induced by subcurative treatment with diminazene aceturate 28 days post-infection.
The animals were treated curatively with melarsoprol upon relapse.
Parasitaemia and clinical signs were monitored daily and, at weekly intervals, the monkeys’ blood and cerebrospinal fluid (CSF) were sampled for haematology and parasitosis assessments, respectively.
Results: The first-peak parasitaemia was observed between seven and nine days post-infection.
Clinical signs associated with the disease included fever, dullness, pallor of mucous membranes, lymphadenopathy, splenomegaly and oedema.
Late-stage signs included stiffness of joints and lethargy.
The monkeys developed a disease associated with microcytic hypochromic anaemia.
There was an initial decline, followed by an increase, in total white blood cell counts from early- to late-stage disease.
Trypanosomes were detected in the CSF and there was a significant increase in white cell counts in the CSF during late-stage disease.
Infected vervet monkeys displayed classical clinical symptoms, parasitological and haematological trends that were similar to monkeys infected withT.
b.
rhodesiense.
Conclusion: The T.
b.
brucei vervet monkey model can be used for studying HAT without putting laboratory technicians and researchers at high risk of accidental infection.

Related Results

Evaluating the prevalence of human and animal african trypanosomiasis in nigeria: A scoping review
Evaluating the prevalence of human and animal african trypanosomiasis in nigeria: A scoping review
ABSTRACT African trypanosomiasis is a protozoan disease that affects both humans and animals. Human African Trypanosomiasis (HAT) is a Neglected Tropical Disease ta...
Prevalence of Human and Animal African Trypanosomiasis in Nigeria: a Scoping Review
Prevalence of Human and Animal African Trypanosomiasis in Nigeria: a Scoping Review
Abstract Background African trypanosomiasis affects both humans (HAT) and animals (AAT). HAT is an NTD targeted for elimination in 2030, and has not been officially report...
Epidemiology of human Monkey-pox cases in Rivers State, Nigeria January 2017-June 2022
Epidemiology of human Monkey-pox cases in Rivers State, Nigeria January 2017-June 2022
The resurgence in monkey pox disease has posed a global health threat. Nigeria recorded increased number of reported monkey pox cases in 2017, with cases occurring in subsequent ye...
Prevalence of bovine trypanosomiasis in the kangaba circle (Mali)
Prevalence of bovine trypanosomiasis in the kangaba circle (Mali)
This study carried out between September and November 2023, in the Kangaba circle aimed to determine the prevalence of trypanosomiasis. Blood samples taken from 219 cattle comprisi...

Back to Top